Everhart Financial Group, Inc.

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1852858 Dublin, OH

Position in REGN

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$337,958

-$171,984 QoQ

Shares Held

542

-17.9% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#230

of 406 holders

Holding Since

Sep 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Everhart Financial Group, Inc. holds $7,789,396 across 11 Biotechnology names. REGN ranks #5 (4.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	SLS	SELLAS Life Sciences Group, Inc.	288,018	$4,251,145
2	VRTX	Vertex Pharmaceuticals Inc / Ma	2,566	$1,274,609
3	ALNY	Alnylam Pharmaceuticals, Inc.	2,646	$796,525
4	BMRN	Biomarin Pharmaceutical Inc	6,995	$400,253
5	REGN	Regeneron Pharmaceuticals, Inc. This page	542	$337,958
6	IONS	Ionis Pharmaceuticals Inc	3,503	$277,752
7	ONCY	Oncolytics Biotech Inc	140,899	$133,854
8	DRTS	Alpha Tau Medical Ltd.	10,000	$125,800

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$337,958	542	-17.9%	Shares	Sole	2026-07-09
2026-03-31	$509,942	660	+43.5%	Shares	Sole	2026-04-09
2025-12-31	$355,060	460	+22.0%	Shares	Sole	2026-01-07
2025-09-30	$211,975	377	-26.4%	Shares	Sole	2025-11-04
2025-03-31	$324,725	512	+45.5%	Shares	Sole	2025-04-16
2024-12-31	$250,740	352	-59.1%	Shares	Sole	2025-01-30
2024-09-30	$904,066	860	+56.4%	Shares	Sole	2024-11-04
2024-06-30	$578,066	550	+14.8%	Shares	Sole	2024-07-24
2024-03-31	$461,032	479	+16.5%	Shares	Sole	2024-05-13
2023-12-31	$360,977	411	+5.9%	Shares	Sole	2024-01-12
2023-09-30	$319,308	388	+13.1%	Shares	Sole	2023-10-25
2023-06-30	$246,459	343	+7.2%	Shares	Sole	2023-07-13
2023-03-31	$262,934	320	+14.3%	Shares	Sole	2023-04-25
2022-12-31	$202,017	280	-27.1%	Shares	Sole	2023-02-09
2022-09-30	$264,526	384	—	Shares	Sole	2022-10-12
No filing history on record for this holder in this stock.